id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-1167-0002,FDA,FDA-2012-N-1167,"Ag-Mark, Inc., et al.; Withdrawal of Approval of New Animal Drug Applications",Notice,Withdrawal,2013-03-07T05:00:00Z,2013,3,,,2013-03-07T14:46:23Z,2013-04998,0,0,090000648121dd97
FDA-2012-N-1167-0003,FDA,FDA-2012-N-1167,New Animal Drug Applications; Alfaprostol; Bicyclohexylammonium Alfaprostol; Bicyclohexylammonium Competitive Exclusion Culture; Dichlorophene and Toluene; Flurogestone Acetate; Isoflurane; Pyrantel; Tylosin; Tylosin and Sulfamethazine,Rule,Final Rule,2013-03-07T05:00:00Z,2013,3,,,2013-03-07T14:56:18Z,2013-04999,0,0,090000648121e015
FDA-2012-N-1167-0001,FDA,FDA-2012-N-1167,"Proposals to Withdraw Approvals of New Animal Drug Applications: Ag-Mark, Inc., et al.; Opportunity for Hearing",Notice,General Notice,2012-12-17T05:00:00Z,2012,12,2012-12-17T05:00:00Z,,2012-12-17T16:30:35Z,2012-30089,0,0,090000648118f699